KNOW Bio's Unattributed - II Round

KNOW Bio raised a round of funding on January 26, 2018.

KNOW Bio, through its subsidiary Novoclem, develops inhalable treatments for antibiotic-resistant pathogens present in cystic fibrosis and other respiratory disease patients. The company is in the pre…

Articles about KNOW Bio's Unattributed - II Round: